Merck ends development of Covid drug it acquired from OncoImmune

Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.